CAPTRUST Financial Advisors’s Covetrus, Inc. Common Stock CVET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-12,437
Closed -$260K 2280
2022
Q3
$260K Buy
12,437
+869
+8% +$18.1K ﹤0.01% 1646
2022
Q2
$240K Sell
11,568
-971
-8% -$17.3K ﹤0.01% 1568
2022
Q1
$211K Buy
12,539
+2,517
+25% +$44K ﹤0.01% 1689
2021
Q4
$200K Buy
10,022
+452
+5% +$8.51K ﹤0.01% 1640
2021
Q3
$174K Sell
9,570
-158
-2% -$3.62K ﹤0.01% 1662
2021
Q2
$263K Buy
9,728
+14
+0.1% +$392 ﹤0.01% 1346
2021
Q1
$291K Buy
9,714
+8,640
+804% +$295K ﹤0.01% 1248
2020
Q4
$31K Buy
1,074
+210
+24% +$5.67K ﹤0.01% 2058
2020
Q3
$21K Buy
864
+304
+54% +$6.56K ﹤0.01% 1958
2020
Q2
$10K Buy
+560
New +$7.36K ﹤0.01% 2199
2019
Q4
Sell
-815
Closed -$10K 1947
2019
Q3
$10K Sell
815
-1,839
-69% -$34K ﹤0.01% 1513
2019
Q2
$65K Buy
2,654
+574
+28% +$16.5K ﹤0.01% 895
2019
Q1
$66K Buy
+2,080
New +$73.8K ﹤0.01% 837

Other funds holding CVET

CAPTRUST Financial Advisors's CVET Position: Q4 2022 in Review

CAPTRUST Financial Advisors sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2022, closing a stake of 12,437 shares — an estimated $260K sold.

CAPTRUST Financial Advisors first reported a position in CVET in Q1 2019 and held it in 13 quarters. The position peaked at $291K in Q1 2021. 5 funds tracked by Wall St. Rank hold CVET as of Q4 2022.

  • CAPTRUST Financial Advisors reported no remaining Covetrus, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 12,437 Covetrus, Inc. Common Stock shares in Q4 2022, an estimated $260K.
  • CAPTRUST Financial Advisors first reported a position in Covetrus, Inc. Common Stock in Q1 2019 and held it in 13 quarters.
  • CAPTRUST Financial Advisors's Covetrus, Inc. Common Stock position peaked at $291K in Q1 2021.
  • 5 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q4 2022, filed 15 Feb 2023.